Syngene, HiMedia collaborate to launch COVID-19 test kits under brand name ELISafe 19 in India

Syngene has indigenously developed an anti-COV-2 IgG ELISA (Enzyme-Linked Immunosorbent Assay) at its research facility in Bengaluru. This advanced highly reliable test identifies the presence of SARS-COV-2 antibodies in blood samples and confirms if a patient has been exposed to the coronavirus. It has the capacity to test samples together in a single run and generates results within 3 hours.

Commenting on the collaboration, Dr Mahesh Bhalgat, Chief Operating Officer, Syngene International Ltd., said, "At a time when the number of COVID-19 cases is increasing at an alarming rate across the country, there is an urgent need to make available reliable testing kits using advanced technology to test patients and identify positive cases. To fill this gap, Syngene, with its expertise across diverse scientific domains, has developed an ELISA kit that allows higher throughput and generates faster results. We are happy to tie-up with HiMedia who will make the kits available at a large scale to significantly increase serological testing in India."

distributing their ELISA kits. This partnership brings together our mutual expertise in research and manufacturing and will further strengthen our fight against the COVID19 pandemic."

Also Read: COVID-19 Testing Kits: Mylab Joins Hands With Syngene International